I’m attending a meeting that is enriched in the older and established luminary type of scientist. Relative to more….democratic academic meetings.

I’ve seen the head of the CSR of the NIH here two years in a row. Now, I don’t know how many meetings this person attends in a year, perhaps it is dozens. I bet not though.

Which means this crowd gets an extra special opportunity to ‘splain what is wrong with grant review and how to fix it.

I guarantee it is mostly about what is good for them with their huge labs and well established programs, and much less about what is good for the riff-raff like us, Dear Reader.